RA CAPITAL MANAGEMENT, L.P. - 06 Jan 2023 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
Director, 10%+ Owner
Signature
/s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol
HOWL
Transactions as of
06 Jan 2023
Net transactions value
+$4,095,130
Form type
4
Filing time
10 Jan 2023, 16:14:16 UTC
Previous filing
06 Jan 2023
Next filing
24 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HOWL Common Stock Purchase $4,095,130 +1,853,000 +48% $2.21 5,701,056 06 Jan 2023 See Footnotes F1, F3
holding HOWL Common Stock 443,825 06 Jan 2023 See Footnotes F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held directly by RA Capital Healthcare Fund, L.P. (the "Fund").
F2 Held directly by RA Capital Nexus Fund II, L.P. (the "Nexus Fund II").
F3 RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund and Nexus Fund II. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Mr. Derek DiRocco, a Partner of the Adviser, serves on the Issuer's board of directors.